Objective To synthesise findings from randomised controlled trials (RCTs) of interventions
aimed at increasing medication adherence in individuals with type 2 diabetes (T2DM) and/or …

Background Between 2 and 43% of patients who receive a new prescription in PC do not
initiate their treatments. Non-initiation is associated with poorer clinical outcomes, more sick …

Objectives Medication adherence in cardiovascular disease (CVD) is reported to be
suboptimal. Therefore, an intervention to tackle non-adherence is important. Pharmacists' …

Background Adherence to multiple cardiovascular (CV) medications is a cornerstone of
coronary heart disease (CHD) management and prevention, but it is sub-optimal worldwide …

Objective To evaluate and compare the effect of interventions for improving adherence to
medications for atherosclerotic cardiovascular disease (ASCVD) secondary prevention …

Cardiovascular disease is the leading cause of death globally. While pharmacological
advancements have improved the morbidity and mortality associated with cardiovascular …

Background Nearly half of patients do not take their cardiovascular medications as
prescribed, resulting in increased morbidity, mortality, and healthcare costs. Mobile and …

Objective Long-term adherence to evidence-based medications in cardiometabolic diseases
remains poor, despite extensive efforts to develop and test interventions and deploy clinician …

Aims The aim of this study was to critically appraise and synthesize the best available
evidence on the effectiveness of interventions suitable for delivery by nurses, designed to …

Background The global prevalence of diabetes is increasing. Medications are a
recommended strategy to control hyperglycaemia. However, patient adherence can be …